Cargando…
From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors
PURPOSE: The aim of this study is to explore the possible benefits of traditional Chinese medicine on the pathogenesis of psychological and mental health of COVID-19 survivors. METHODS: A literature search was conducted to confirm the effects of COVID-19 on psychological and mental health of survivo...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524684/ https://www.ncbi.nlm.nih.gov/pubmed/33053508 http://dx.doi.org/10.1016/j.biopha.2020.110810 |
_version_ | 1783588592126263296 |
---|---|
author | Ma, Ke Wang, Xin Feng, Shiyao Xia, Xueshan Zhang, Hongxiu Rahaman, Abdul Dong, Zhenfei Lu, Yanting Li, Xiuyang Zhou, Xiaoyu Zhao, Haijun Wang, Yuan Wang, Shijun Baloch, Zulqarnain |
author_facet | Ma, Ke Wang, Xin Feng, Shiyao Xia, Xueshan Zhang, Hongxiu Rahaman, Abdul Dong, Zhenfei Lu, Yanting Li, Xiuyang Zhou, Xiaoyu Zhao, Haijun Wang, Yuan Wang, Shijun Baloch, Zulqarnain |
author_sort | Ma, Ke |
collection | PubMed |
description | PURPOSE: The aim of this study is to explore the possible benefits of traditional Chinese medicine on the pathogenesis of psychological and mental health of COVID-19 survivors. METHODS: A literature search was conducted to confirm the effects of COVID-19 on psychological and mental health of survivors. In addition to this, on the basis of signs and symptoms, TCM were used on treat mental disorder as per suggested clinical and animal experimental data plus relevant records in classical Chinese medicine books written by Zhang Zhongiing during Han Dynasty. A series of treatment plans were prescribed for COVID-19 survivors with psychological and mental disorders. RESULTS: According to previous extensive studies focusing on effects on mental health of survivors, high incidence was observed in severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) survivors. During investigations of mental health of COVID-19 patients and survivors, it is observed that they also had symptoms of mental disorders and immune dysfunction. Furthermore, it was also proposed that depression, anxiety and post-traumatic stress disorder (PTSD) were most common mental disorders requiring special attention after the recovery from COVID-19. The symptoms of COVID-19 were analyzed, and the TCM syndrome of the depression, anxiety and PTSD after recovered from COVID19 was interpreted as internal heat and Yin deficiency. These three mental disorders pertains the category of “Lily disease”, “hysteria” and “deficient dysphoria” in TCM. CONCLUSION: Lily Bulb, Rhizoma Anemarrhena Decoction and Ganmai Dazao Decoction were used to treat depression. Suanzaoren Decoction, Huanglian Ejiao Decoction and Zhizi Chi Decoction were suggested for anxiety. Moreover, Lily Bulb, Rehmannia Decoction and Guilu Erxian Decoction were the formula for PTSD. |
format | Online Article Text |
id | pubmed-7524684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Authors. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75246842020-09-30 From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors Ma, Ke Wang, Xin Feng, Shiyao Xia, Xueshan Zhang, Hongxiu Rahaman, Abdul Dong, Zhenfei Lu, Yanting Li, Xiuyang Zhou, Xiaoyu Zhao, Haijun Wang, Yuan Wang, Shijun Baloch, Zulqarnain Biomed Pharmacother Review PURPOSE: The aim of this study is to explore the possible benefits of traditional Chinese medicine on the pathogenesis of psychological and mental health of COVID-19 survivors. METHODS: A literature search was conducted to confirm the effects of COVID-19 on psychological and mental health of survivors. In addition to this, on the basis of signs and symptoms, TCM were used on treat mental disorder as per suggested clinical and animal experimental data plus relevant records in classical Chinese medicine books written by Zhang Zhongiing during Han Dynasty. A series of treatment plans were prescribed for COVID-19 survivors with psychological and mental disorders. RESULTS: According to previous extensive studies focusing on effects on mental health of survivors, high incidence was observed in severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) survivors. During investigations of mental health of COVID-19 patients and survivors, it is observed that they also had symptoms of mental disorders and immune dysfunction. Furthermore, it was also proposed that depression, anxiety and post-traumatic stress disorder (PTSD) were most common mental disorders requiring special attention after the recovery from COVID-19. The symptoms of COVID-19 were analyzed, and the TCM syndrome of the depression, anxiety and PTSD after recovered from COVID19 was interpreted as internal heat and Yin deficiency. These three mental disorders pertains the category of “Lily disease”, “hysteria” and “deficient dysphoria” in TCM. CONCLUSION: Lily Bulb, Rhizoma Anemarrhena Decoction and Ganmai Dazao Decoction were used to treat depression. Suanzaoren Decoction, Huanglian Ejiao Decoction and Zhizi Chi Decoction were suggested for anxiety. Moreover, Lily Bulb, Rehmannia Decoction and Guilu Erxian Decoction were the formula for PTSD. The Authors. Published by Elsevier Masson SAS. 2020-12 2020-09-30 /pmc/articles/PMC7524684/ /pubmed/33053508 http://dx.doi.org/10.1016/j.biopha.2020.110810 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Ma, Ke Wang, Xin Feng, Shiyao Xia, Xueshan Zhang, Hongxiu Rahaman, Abdul Dong, Zhenfei Lu, Yanting Li, Xiuyang Zhou, Xiaoyu Zhao, Haijun Wang, Yuan Wang, Shijun Baloch, Zulqarnain From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors |
title | From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors |
title_full | From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors |
title_fullStr | From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors |
title_full_unstemmed | From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors |
title_short | From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors |
title_sort | from the perspective of traditional chinese medicine: treatment of mental disorders in covid-19 survivors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524684/ https://www.ncbi.nlm.nih.gov/pubmed/33053508 http://dx.doi.org/10.1016/j.biopha.2020.110810 |
work_keys_str_mv | AT make fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT wangxin fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT fengshiyao fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT xiaxueshan fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT zhanghongxiu fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT rahamanabdul fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT dongzhenfei fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT luyanting fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT lixiuyang fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT zhouxiaoyu fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT zhaohaijun fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT wangyuan fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT wangshijun fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors AT balochzulqarnain fromtheperspectiveoftraditionalchinesemedicinetreatmentofmentaldisordersincovid19survivors |